As a dynamically developing company with an international footprint, the MPA Pharma group's core activities are in the reimport and parallel import of EU medicinal products, trade with pharmaceuticals and medical devices, and contract manufacturing services for third parties. As a market leader, MPA Pharma has expertise in the pharmaceuticals market. MPA Pharma’s strong partnership ethic in dealing with customers, the long-standing, extensive expertise of its around 640 employees and its comprehensive product range offered on fair terms form the basis of long-lasting and successful business relationships.
The MPA Pharma group is owner-managed and its headquarters is located in Trittau, near Hamburg in Germany. It is the sole parent company of the distribution subsidiary EMRAmed, which is based in Germany and operates in the German-speaking world. Since 2012, the MPA Pharma group has been the majority shareholder of Paranova Group A/S. Effective November 2016, MPA Pharma group assumes the remaining share of Paranova Group A/S and thus becoming a 100% shareholder.